Godavari Drugs Limited

Company Profile

Godavari Drugs Limited had its IPO on under the ticker symbol 530317.

The company operates in the Other sector and Other industry. Godavari Drugs Limited has a staff strength of 101 employees.

Stock update

Shares of Godavari Drugs Limited opened at ₹102 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹97.25 - ₹102, and closed at ₹98.95.

This is a -3.13% slip from the previous day's closing price.

A total volume of 24,950 shares were traded at the close of the day’s session.

In the last one week, shares of Godavari Drugs Limited have slipped by -9.22%.

Godavari Drugs Limited's Key Ratios

Godavari Drugs Limited has a market cap of ₹270.34 million, indicating a price to book ratio of 1.3122 and a price to sales ratio of 0.2673.

In the last 12-months Godavari Drugs Limited’s revenue was ₹992.58 million with a gross profit of ₹190.19 million and an EBITDA of ₹69.42 million. The EBITDA ratio measures Godavari Drugs Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Godavari Drugs Limited’s operating margin was 5.8% while its return on assets stood at 0% with a return of equity of 0%.

In Q2, Godavari Drugs Limited’s quarterly earnings growth was a positive 98.4% while revenue growth was a positive 15%.

Godavari Drugs Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

10.9627

PEG

Its diluted EPS in the last 12-months stands at ₹3.223 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Godavari Drugs Limited’s profitability.

Godavari Drugs Limited stock is trading at a EV to sales ratio of 0.5422 and a EV to EBITDA ratio of 8.8657. Its price to sales ratio in the trailing 12-months stood at 0.2673.

Godavari Drugs Limited stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹1.21 billion

Total Liabilities

₹737.08 million

Operating Cash Flow

₹-86385000.00

Capital Expenditure

₹92.97 million

Dividend Payout Ratio

0%

Godavari Drugs Limited ended 2024 with ₹1.21 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.21 billion while shareholder equity stood at ₹334.17 million.

Godavari Drugs Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹737.08 million in other current liabilities, 75305000.00 in common stock, ₹258.87 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹30.85 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹119.48 million.

Godavari Drugs Limited’s total current assets stands at ₹870.06 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹579.35 million compared to accounts payable of ₹0 and inventory worth ₹198.56 million.

In 2024, Godavari Drugs Limited's operating cash flow was ₹-86385000.00 while its capital expenditure stood at ₹92.97 million.

Comparatively, Godavari Drugs Limited paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹98.95

52-Week High

₹109.95

52-Week Low

₹57

Analyst Target Price

₹

Godavari Drugs Limited stock is currently trading at ₹98.95 per share. It touched a 52-week high of ₹109.95 and a 52-week low of ₹109.95. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹99.87 and 200-day moving average was ₹86.94 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6625.7% of the company’s stock are held by insiders while 0% are held by institutions.